Results 131 to 140 of about 131,813 (277)

A Model of Regulatory Burden in Technology Diffusion: The Case of Plant-Derived Vaccines. [PDF]

open access: yes
Plant-derived vaccines may soon displace conventional vaccines. Assuming there are no major technological barriers undermining the feasibility of this innovative technology, it is worthwhile to generate quantitative models of regulatory burden of ...
Bérard, Céline   +4 more
core  

Exploring the Causes of Low Immunization Status in School Going Children [PDF]

open access: yes, 2012
Background: Although a definitive immunization program has been advocated for children in our country, the immunization coverage is far from satisfactory. There is paucity of survey studies related to immunization pattern.
Inamdar, M   +3 more
core   +1 more source

A Personalised Vaccination Program Based on Immune Reconstitution in Paediatric Cancer Survivors

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aims Paediatric cancer survivors often experience treatment‐induced immunosuppression, requiring post‐treatment revaccination. However, immune recovery timelines vary, and current revaccination guidelines, largely based on data of varied quality derived from studies on acute‐lymphoblastic‐leukaemia (ALL), may not be applicable across all ...
Menucha Jurkowicz   +17 more
wiley   +1 more source

Diagnostic Impact of Liver Biopsy Among Antinuclear Antibody Positive Individuals With Mild Liver Enzyme Elevation

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
In ANA‐positive patients with suspected autoimmune hepatitis (AIH), liver biopsy rarely altered therapeutic management when alanine aminotransferase (ALT) was below 101 U/L and cirrhosis was absent. These findings suggest that biopsy may be safely deferred in this low‐risk group.
David Mehdi Asgher Niazi   +8 more
wiley   +1 more source

Mission 2030: Toward universal hepatitis B immunization

open access: yesHuman Vaccines & Immunotherapeutics
Despite the availability of efficacious and safe vaccines for more than 40 years, the rate of new hepatitis B virus (HBV) infections remains high, leaving large populations at risk of developing chronic hepatitis B, liver cirrhosis and cancer.
Elias Broeckhoven, Kai Dallmeier
doaj   +1 more source

The potential demand for and strategic use of an HIV-1 vaccine in Southern India [PDF]

open access: yes
Even a modestly effective HIV-1 vaccine would be highly useful in India and could avoid millions of deaths. How should such a vaccine be introduced? Based on evidence of adoption of other vaccines in India, current levels of spending on them and coverage
Jha, Prabhat   +2 more
core  

Hepatitis A Vaccine

open access: yesRGUHS Journal of Medical Sciences, 2015
None
openaire   +1 more source

Assessing Risk Thresholds in Controlled Human Infection Models (CHIM)

open access: yesBioethics, EarlyView.
ABSTRACT Controlled Human Infection Models (CHIMs) are a type of clinical trial involving deliberately exposing human volunteers to an infectious agent. Compared to studies of natural infection, CHIMs offers distinctive benefits, from the ability to study presymptomatic infection to a direct assessment of the efficacy of vaccines and therapeutics in a ...
Alexa Nord‐Bronzyk   +4 more
wiley   +1 more source

Study on the performance enhancement of biomedical implants: in vitro test under UV irradiation of titanium anodised in mixed electrolyte [PDF]

open access: yes, 2018
Titanium (Ti) recently has widely been used in the biomedical applications due to its high performance. Therefore, surface modifications of titanium have attracted a lot of interest to provide better osseointegration.
Elfallah, Saleh S Saleh
core  

Prevalent vaccination practices among Indian Allopathic non-pediatrician doctors for their own children: A proxy indicator of updated knowledge about childhood immunization [PDF]

open access: yesAl Ameen Journal of Medical Sciences, 2017
Background: It has been hypothesized that the general physicians and specialists other than pediatricians operating in the private sectors of India do not access regular updates about the newer, and additional vaccines i.e., non-national schedule ...
Priyanka Gupta   +3 more
doaj  

Home - About - Disclaimer - Privacy